CKD as a Risk Factor for Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

American Journal of Kidney Diseases

Volumn 50, Issue 5, 2007, Pages 743-753

  Chung, Shiu Dong ^a,b   Huang, Kuo How ^b   Lai, Ming Kuen ^b   Huang, Chao Yuan ^b   Chen, Chung Hsin ^b   Pu, Yeong Shiau ^b   Yu, Hong Jeng ^b   Chueh, Shih Chieh ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

bladder recurrence; chronic kidney disease (CKD); nephroureterectomy; upper urinary tract; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIET; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HERBAL MEDICINE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROURETERECTOMY; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; URETER TUMOR; URINARY TRACT CARCINOMA;

AGED; COMORBIDITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; NEPHRECTOMY; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; URETERAL NEOPLASMS; URETEROCELE; URINARY BLADDER NEOPLASMS;

EID: 35348982923     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.08.007     Document Type: Article

References (30)

1. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics 1998. CA Cancer J Clin 48 (1998) 6-29
2. Yang M.H., Chen K.K., Yen C.C., et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 59 (2002) 681-687
3. Hsieh Y.F., Ling G.C., Lu Y.B., Yeh M.T., and Chiang C.P. Incidence of tumor of the renal pelvis in Taiwan. J Formos Med Assoc 78 (1979) 749-753
4. Cummings K.B. Nephroureterectomy: Rationale in the management of primary transitional cell carcinoma of the upper urinary tract. Urol Clin North Am 7 (1980) 569-578
5. Kikuchi E., Horiguchi Y., Nakashima J., et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 174 (2005) 2120-2123
6. Akdogan B., Dogan H.S., Eskicorapsi S.Y., Sahin A., Erkan I., and Ozen H. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 176 (2006) 48-52
7. Langner C., Hutterer G., Chromecki T., Leibl S., Rehak P., and Ziguener R. Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. J Urol 176 (2006) 910-913
8. Hall M.C., Womack S., Sagalowsky A.I., Carmody T., Erickstad M.D., and Roehrborn C.G. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology 52 (1998) 594-601
9. Park S., Hong B., Kim C.S., and Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 171 (2004) 621-625
10. Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65 (2005) 279-283
11. Maisonneuve P., Agodoa L., Gellert R., et al. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 354 (1999) 93-99
12. Chen K.S., Lai M.K., Huang C.C., Chu S.H., and Leu M.L. Urologic cancers in uremic patients. Am J Kidney Dis 25 (1995) 694-700
13. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
14. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130 (1999) 461-470
15. American Joint Committee on Cancer. Renal pelvis and ureter. AJCC Cancer Staging Manual. ed 6 (2002), Springer, New York, NY 329-334
16. Mostofi F.K., Sorbin L.H., and Torloni H. Histological Typing of Urinary Bladder Tumors. International Histological Classification of Tumors. No. 10 (1973), World Health Organization, Geneva, Switzerland
17. Stewart J.H., Buccianti G., Agodoa L., et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: Analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14 (2003) 197-207
18. Vamvakas S., Bahner U., and Heidland A. Cancer in end-stage renal disease: Potential factors involved. Am J Nephrol 18 (1998) 89-95
19. Stopper H., Meysen T., Bockenforde A., Bahner U., Heidland A., and Vamvakas S. Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am J Kidney Dis 34 (1999) 433-437
20. Kohler H., Girndt M., Dumann H., and Klingel R. [The immune defect in kidney failure. II. The mechanisms of the "uremic" immune defect]. Dtsch Med Wochenschr 118 (1993) 790-795
21. Wu C.F., Chang P.L., Chen C.S., Chuang C.K., Weng H.H., and Pan S.T. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 176 (2006) 477-481
22. Kang C.H., Yu T.J., Hsieh H.H., et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98 (2003) 1620-1626
23. Ou J.H., Pan C.C., Lin J.S., et al. Transitional cell carcinoma in dialysis patients. Eur Urol 37 (2000) 90-94
24. Takahashi T., Habuchi T., Kakehi Y., et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 58 (1998) 5835-5841
25. Vriesema J.L., Aben K.K., Witjes J.A., Kiemeney L.A., and Schalken J.A. Superficial and metachronous invasive bladder carcinomas are clonally related. Int J Cancer 93 (2001) 699-702
26. Hafner C., Knuechel R., Zarnado L., et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 20 (2001) 4910-4915
27. Ziguener R.E., Hutterer G., Chromacki T., Rehak P., and Langner C. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 98 (2006) 1181-1186
28. Marsit C.J., Karagas M.R., Danaee H., et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 27 (2006) 112-116
29. Hartge P., Silverman D., Hoover R., et al. Changing cigarette habits and bladder cancer risk: A case-control study. J Natl Cancer Inst 78 (1987) 1119-1125
30. Raman J.D., Ng C.K., Boorjian S.A., Vaughan Jr. E.D., Sosa R.E., and Scherr D.S. Bladder cancer after managing upper urinary tract transitional cell carcinoma: Predictive factors and pathology. BJU Int 96 (2005) 1031-1035